New home blood pressure program aims to tame hypertension remotely
NCT ID NCT05300503
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a remote telehome monitoring program for 100 people with high blood pressure who receive virtual care. Participants used a special blood pressure cuff and a monitoring platform to share readings with their doctors. The goal was to see if this approach improves blood pressure control compared to usual care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Telehome monitoring program (behavioral intervention using a special blood pressure cuff and monitoring platform)
What this could lead to
If successful, this program could help patients with high blood pressure get better control of their condition from home, reducing the risk of serious health problems.
What could go wrong
This is a small pilot study with only 100 participants, so results may not apply to everyone. The program relies on technology and patient engagement, which may not work for all.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The University of Ottawa Heart Institute
Ottawa, Ontario, K1Y4W7, Canada